Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK (2021)

First Author: Voysey M

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(20)32661-1

Publication URI: http://dx.doi.org/10.1016/s0140-6736(20)32661-1

Type: Journal Article/Review

Parent Publication: The Lancet

Issue: 10269